Real-time pulmonary artery pressure monitoring in heart failure patients: an updated cost-effectiveness analysis.

Martin R Cowie,Praveen Thokala,Zenichi Ihara,Philip B Adamson,Christiane Angermann

ESC heart failure（2023）

引用 1|浏览13

暂无评分

摘要

Our model suggests that CardioMEMS is likely to be cost-effective in the United Kingdom, at the currently considered thresholds of £20 000-30 000/QALY.

查看译文

关键词

heart failure patients,heart failure,cost‐effectiveness cost‐effectiveness

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要